Schizophrenia and Related Disorders
55
13
13
26
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
5 terminated out of 55 trials
83.9%
-2.6% vs benchmark
5%
3 trials in Phase 3/4
19%
5 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (55)
Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia
Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia
Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS
"Extended" (Alternate Day) Antipsychotic Dosing
Substance Misuse To Psychosis for Stimulants
Social Isolation and Aging in Schizophrenia
Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in India
Clay Therapy in Schizophrenia Patients
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients
Exercise Therapy in Mental Disorders-study
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
SPARK Healthy Sleep
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
The Police-Mental Health Linkage System
Tele-group Cognitive Behavioural Family Intervention for Individuals With Schizophrenia and Their Families
EEG Outcomes From Cognitive Behavioural Therapy for Psychosis
Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
Cultural Adaptation of Group CBT Psychosis Manual and Establishing Its Efficacy in Pakistan